[1]
|
Kunutsor, S.K., Kieneker, L.M., Bakker, S.J.L., James, R.W. and Dullaart, R.P.F. (2017) Incident Type 2 Diabetes Is Associated with HDL, But Not with Its Anti-Oxidant Constituent—Paraoxonase-1: The Prospective Cohort PREVEND Study. Metabolism, 73, 43-51. https://doi.org/10.1016/j.metabol.2017.05.004
|
[2]
|
Yang, S.H., Du, Y. and Li, X.L. (2017) Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics with Coronary Artery Disease. The American Journal of the Medical Sciences, 354, 117-124. https://doi.org/10.1016/j.amjms.2017.03.032
|
[3]
|
Chang, T.I., Streja, E. and Moradi, H. (2017) Could High-Density Lipoprotein Cholesterol Predict Increased Cardiovascular Risk. Current Opinion in Endocrinology, Diabetes and Obesity, 24, 140-147. https://doi.org/10.1097/MED.0000000000000318
|
[4]
|
Hermans, M.P., Valensi, P. and Ahn, S.A. (2018) [HDL-C/apoA-I]: A Multi-Vessel Cardiometabolic Risk Marker in Women with T2DM. Diabetes/Metabolism Research and Reviews, 34, 829-840. https://doi.org/10.1002/dmrr.2950
|
[5]
|
Wiesner, P., Leidl, K., Boettcher, A., Schmitz, G. and Liebisch, G. (2009) Lipidprofiling of FPLC-Separated Lipoprotein Fractions by Electrosprayionization Tandem Mass Spectrometry. The Journal of Lipid Research, 50, 574-585. https://doi.org/10.1194/jlr.D800028-JLR200
|
[6]
|
Van Linthout, S., Spillmann, F., Schultheiss, H.P. and Tschöpe, C. (2010) High-Density Lipoprotein at the Interface of Type 2 Diabetes Mullitus and Cardiovascular Disorders. Current Pharmaceutical Design, 16, 1504-1516.
|
[7]
|
Park, K.H., Shin, D.G. and Cho, K.H. (2014) Dysfunctional Lipoproteins from Young Smokers Exacerbate Cellular Senescence and Atherogenesis with Smaller Partical Size and Severe Oxidation and Glycation. Toxicological Sciences, 140, 16-25. https://doi.org/10.1093/toxsci/kfu076
|
[8]
|
Shao, B., Tang, C., Sinha, A., Mayer, P.S., Davenport, G.D., Brot, N., et al. (2014) Humans with Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase. Circulation Research, 114, 1733-1742. https://doi.org/10.1161/CIRCRESAHA.114.303454
|
[9]
|
Mackness, M. and Mackness, B. (2015) Human Paraoxonase-1 (PON1): Gene Structure and Expression, Promiscuous Activities and Multiple Physiological Roles. Gene, 567, 12-21. https://doi.org/10.1016/j.gene.2015.04.088
|
[10]
|
Rosenson, R.S., Brewer, H.B., Davidson, W.S., Fayad, Z.A., Fuster, V., Goldstein, J., et al. (2012) Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport. Circulation, 125, 1905-1919. https://doi.org/10.1161/CIRCULATIONAHA.111.066589
|
[11]
|
Wang, X., Collins, H.L., Ranalletta, M., Fuki, I.V., Billheimer, J.T., et al. (2007) Macrophage ABCA1 and ABCG1, But Not SR-BI, Promote Macrophage Reverse Cholesterol Transport in Vivo. Journal of Clinical Investigation, 117, 2216-2224. https://doi.org/10.1172/JCI32057
|
[12]
|
Rosamond, W., Flegal, K., Friday, G., et al. (2007) Heart Disease and Stroke Statistics—2007 Update: A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 115, 69-71.
|
[13]
|
Oda, M.N. (2015) High-Density Lipoprotein Cholesterol: Origins and the Path Ahead. Current Opinion in Endocrinology, Diabetes and Obesity, 22, 133-141. https://doi.org/10.1097/MED.0000000000000139
|
[14]
|
Hirschler, V., Maccallini, G., Sanchez, M., Gonzalez, C. and Molinari, C. (2015) Association between Triglyceride to HDL-C Ratio and Insulin Resistance in Indigenous Argentinean Children. Pediatric Diabetes, 16, 606-612. https://doi.org/10.1111/pedi.12228
|
[15]
|
Rosenson, R.S., Brewer, H.B., Ansell, B.J., et al. (2016) Dysfunctional HDL and Atherosclerotic Cardiovascular Disease. Nature Reviews Cardiology, 13, 48-60. https://doi.org/10.1038/nrcardio.2015.124
|
[16]
|
Rosenson, R.S., Brewer Jr., H.B., Ansell, B., et al. (2013) Translation of High-Density Lipoprotein Function into Clinical Practice: Current Prospects and Future Challenges. Circulation, 128, 1256-1267. https://doi.org/10.1161/CIRCULATIONAHA.113.000962
|
[17]
|
AIM-HIGH Investigators, Boden, W.E., Probstfield, J.L., et al. (2011) Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Stat in Therapy. The New England Journal of Medicine, 367, 2255-2267. https://doi.org/10.1056/NEJMoa1107579
|
[18]
|
Voight, B.F., Peloso, G.M., Orho-Melander, M., et al. (2012) Plasma HDL Cholesterol and Risk of Myocardial Infarction: A Mendelian Randomisation Study. The Lancet, 380, 572-580. https://doi.org/10.1016/S0140-6736(12)60312-2
|
[19]
|
Huang, M.C., Chang, W.T., Chang, H.Y., et al. (2017) FADS Gene Polymorphisms, Fatty Acid Desaturase Activities, and HDL-C in Type 2 Diabetes. International Journal of Environmental Research and Public Health, 14, pii: E572.
|
[20]
|
Pérez-Méndez, ó., Pacheco, H.G., Martínez-Sánchez, C., et al. (2014) HDL-Cholesterol in Coronary Artery Disease Risk: Function or Structure? Clinica Chimica Acta, 429, 111-122. https://doi.org/10.1016/j.cca.2013.12.001
|
[21]
|
Song, X., Teng, J., Wang, A., et al. (2016) Positive Correlation between Serum IGF-1 and HDL-C in Type 2 Diabetes Mellitus. Diabetes Research and Clinical Practice, 118, 44-49. https://doi.org/10.1016/j.diabres.2016.04.056
|
[22]
|
Patel, S., Puranik, R., Nakhla, S., et al. (2009) Acute Hypertriglyceridaemia in Humans Increases the Triglyceride Content and Decreases the Anti-Inflammatory Capacity of High Density Lipoproteins. Atherosclerosis, 204, 424-428. https://doi.org/10.1016/j.atherosclerosis.2008.07.047
|
[23]
|
Zhang, L., Chen, S., Deng, A., Liu, X., Liang, Y., Shao, X., et al. (2015) Association between Lipid Ratios and Insulin Resistance in a Chinese Population. PLoS ONE, 10, e0116110.
|
[24]
|
Baldan, A., Tarr, P., Lee, R. and Edwards, P.A. (2006) ATP-Binding Cassette Transporter G1 and Lipid Homeostasis. Current Opinion in Lipidology, 17, 227-232. https://doi.org/10.1097/01.mol.0000226113.89812.bb
|
[25]
|
Mauldin, J.P., Srinivasan, S., Mulya, A., et al. (2006) Reduction in ABCG1 in Type 2 Diabetic Mice Increases Macrophage Foam Cell Formation. Biological Chemistry, 281, 21216-21224. https://doi.org/10.1074/jbc.M510952200
|
[26]
|
Barbarossa, G., Renzi, A., D’Erasmo, L., et al. (2014) The Relation between Glycemic Control and HDL-C in Type 2 Diabetes: A Preliminary Step Forward? Diabetes Research and Clinical Practice, 104, 26-28. https://doi.org/10.1016/j.diabres.2013.12.061
|
[27]
|
Uehara, Y., Engel, T., Li, Z., et al. (2002) Polyunsaturated Fatty Acids and Acetoacetate Downregulate the Expression of the ATP-Binding Cassette Transporter A1. Diabetes, 51, 2922-2928. https://doi.org/10.2337/diabetes.51.10.2922
|
[28]
|
Chait, A., Han, C.Y., Oram, J.F., et al. (2005) Thematic Review Series: The Immune System and Atherogenesis. Lipoprotein-Associated Inflammatory Proteins: Markers or Mediators of Cardiovascular Disease? The Journal of Lipid Research, 46, 389-403. https://doi.org/10.1194/jlr.R400017-JLR200
|
[29]
|
Ina, K., Hayashi, T., Araki, A., et al. (2014) Importance of High-Density Lipoprotein Cholesterol Levels in Elderly Diabetic Individuals with Type IIb Dyslipidemia: A 2-Year Survey of Cardiovascular Events. Geriatrics & Gerontology International, 14, 806-810. https://doi.org/10.1111/ggi.12168
|
[30]
|
Passarelli, M., Tang, C., McDonald, T.O., et al. (2005) Advanced Glycation End Product Precursorsimpair ABCA1-Dependent Cholesterol Removal from Cells. Diabetes, 54, 2198-2205. https://doi.org/10.2337/diabetes.54.7.2198
|
[31]
|
McGillicuddy, F.C., de la LleraMoya, M., Hinkle, C.C., et al. (2009) Inflammation Impairs Reverse Cholesterol Transport in Vivo. Circulation, 119, 1135-1145. https://doi.org/10.1161/CIRCULATIONAHA.108.810721
|
[32]
|
Sorrentino, S.A., Besler, C., Rohrer, L., et al. (2010) Endothelial-Vasoprotective Effects of High Density Lipoprotein Are Impaired in Patients with Type 2 Diabetes Mellitus But Are Improved after Extended-Release Niacin Therapy. Circulation, 12, 110-122. https://doi.org/10.1161/CIRCULATIONAHA.108.836346
|
[33]
|
Annema, W., Nijstad, N., Tolle, M., et al. (2010) Myeloperoxidase and Serumamyloid A Contribute to Impaired in Vivo Reverse Cholesterol Transport during the Acute Phase Response But Not Group IIA Secretory Phospholipase A(2). The Journal of Lipid Research, 51, 743-754. https://doi.org/10.1194/jlr.M000323
|
[34]
|
Zerrad-Saadi, A., Therond, P., Chantepie, S., et al. (2009) HDL3-Mediated Inactivation of LDL Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipidrigidity: Relevance Toinflammation and Atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 2169-2175. https://doi.org/10.1161/ATVBAHA.109.194555
|
[35]
|
Briand, F., Prunet-Marcassus, B., Thieblemont, Q., et al. (2014) Raising HDL with CETP Inhibitor Torcetrapib Improves Glucose Homeostasis in Dyslipidemic and Insulin Resistant Hamsters. Atherosclerosis, 233, 359-362. https://doi.org/10.1016/j.atherosclerosis.2014.01.028
|
[36]
|
Njajou, O.T., Kanaya, A.M., Holvoet, P., et al. (2009) Association between Oxidized LDL, Obesity and Type 2 Diabetes in a Population-Based Cohort, the Health, Aging and Body Composition Study. Diabetes/Metabolism Research and Reviews, 25, 733-739. https://doi.org/10.1002/dmrr.1011
|
[37]
|
Liu, F. and Huang, L. (2001) Improving Plasmid DNA-Mediated Liver Gene Transfer by Prolonging Its Retention in the Hepatic Vasculature. The Journal of Gene Medicine, 3, 569-576. https://doi.org/10.1002/jgm.222
|
[38]
|
Von Eckardstein, A. and Widmann, C. (2014) High-Density Lipoprotein, Beta Cells, and Diabetes. Cardiovascular Research, 103, 384-394. https://doi.org/10.1093/cvr/cvu143
|
[39]
|
Nobecourt, E., Jacqueminet, S., Hansel, B., et al. (2005) Defective Antioxidative Activity of Small Dense HDL3 Particles in Type 2 Diabetes: Relationship to Elevated Oxidative Stress and Hyperglycaemia. Diabetologia, 48, 529-538. https://doi.org/10.1007/s00125-004-1655-5
|
[40]
|
Kon, V., Yang, H. and Fazio, S. (2015) Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-Density Lipoprotein. Archives of Medical Research, 46, 379-391. https://doi.org/10.1016/j.arcmed.2015.05.009
|
[41]
|
Mastorikou, M., Mackness, B., Liu, Y., et al. (2008) Glycation of Paraoxonase-1 Inhibits Its Activity and Impairs the Ability of High Density Lipoprotein to Metabolize Membrane Lipid Hydroperoxides. Diabetic Medicine, 25, 1049-1055. https://doi.org/10.1111/j.1464-5491.2008.02546.x
|
[42]
|
Rozenberg, O., Shih, D.M. and Aviram, M. (2005) Paraoxonase 1 (PON1) Attenuates Macrophage Oxidative Status: Studies in PON1 Transfected Cells and in PON1 Transgenic Mice. Atherosclerosis, 181, 9-18. https://doi.org/10.1016/j.atherosclerosis.2004.12.030
|
[43]
|
Feingold, K.R. and Grunfeld, C. (2016) Effect of Inflammation on HDL Structure and Function. Current Opinion in Lipidology, 27, 521-530. https://doi.org/10.1097/MOL.0000000000000333
|
[44]
|
Rozenberg, O., Rosenblat, M., Coleman, R., et al. (2003) Paraoxonase (PON1) Deficiency Is Associated with Increased Macrophage Oxidative Stress: Studies in PON1-Knockout Mice. Free Radical Biology & Medicine, 34, 774-784. https://doi.org/10.1016/S0891-5849(02)01429-6
|
[45]
|
Modi, K.D., Chandwani, R., Ahmed, I., et al. (2016) Discordance between Lipid Markers Used for Predicting Cardiovascular Risk in Patients with Type 2 Diabetes. Diabetology & Metabolic Syndrome, 10, 99-102. https://doi.org/10.1016/j.dsx.2015.10.002
|
[46]
|
Persegol, L., Verges, B., Foissac, M., et al. (2006) Inability of HDL from Type 2 Diabetic Patients to Counteract the Inhibitory Effect of Oxidised LDL on Endothelium-Dependent Vasorelaxation. Diabetologia, 49, 1380-1386. https://doi.org/10.1007/s00125-006-0244-1
|
[47]
|
Riwanto, M., Rohrer, L., Roschitzki, B., et al. (2013) Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density lipoprotein Proteome Remodeling. Circulation, 127, 891-904. https://doi.org/10.1161/CIRCULATIONAHA.112.108753
|
[48]
|
Vita, J.A., Brennan, M.L., Gokce, N., et al. (2004) Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans. Circulation, 110, 1134-1139. https://doi.org/10.1161/01.CIR.0000140262.20831.8F
|
[49]
|
van der Stoep, M., Korporaal, S.J. and Van Eck, M. (2014) High-Density Lipoprotein as a Modulator of Platelet and Coagulation Responses. Cardiovascular Research, 103, 362-371. https://doi.org/10.1093/cvr/cvu137
|
[50]
|
Feng, Y., Jacobs, F., Van Craeyveld, E., et al. (2008) Human ApoA-I Transfer Attenuates Transplant Arteriosclerosis via Enhanced Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 278-283. https://doi.org/10.1161/ATVBAHA.107.158741
|
[51]
|
Lupattelli, G., Marchesi, S., Roscini, A.R., et al. (2002) Direct Association between High-Density Lipoprotein Cholesterol and Endothelial Function in Hyperlipemia. American Journal of Cardiology, 90, 648-650. https://doi.org/10.1016/S0002-9149(02)02575-4
|
[52]
|
Ren, X., Chen, Z.A., Zheng, S., et al. (2016) Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus. PLoS ONE, 11, e0154345. https://doi.org/10.1371/journal.pone.0154345
|
[53]
|
Hanefeld, M., Traylor, L., Gao, L., et al. (2017) The Use of Lipid-Lowering Therapy and Effects of Antihyperglycaemic Therapy on Lipids in Subjects with Type 2 Diabetes with or without Cardiovascular Disease: A Pooled Analysis of Data from Eleven Randomized Trials with Insulin Glargine 100 U/ml. Cardiovascular Diabetology, 16, 66. https://doi.org/10.1186/s12933-017-0548-0
|
[54]
|
Quispe, R., Martin, S.S., Jones, S.R., et al. (2016) Triglycerides to High-Density Lipoprotein-Cholesterol Ratio, Glycemic Control and Cardiovascular Risk in Obese Patients with Type 2 Diabetes. Current Opinion in Endocrinology, Diabetes and Obesity, 23, 150-156. https://doi.org/10.1097/MED.0000000000000241
|
[55]
|
Oak, J.H. and Cai, H. (2007) Attenuation of Angiotensin II Signaling Recouplesenos and Inhibits Nonendothelial NOX Activity in Diabetic Mice. Diabetes, 56, 118-126. https://doi.org/10.2337/db06-0288
|
[56]
|
Kong, D., Melo, L.G., Mangi, A.A., et al. (2004) Enhanced Inhibition of Neointimal Hyperplasia by Genetically Engineered Endothelial Progenitor Cells. Circulation, 109, 1769-1775. https://doi.org/10.1161/01.CIR.0000121732.85572.6F
|
[57]
|
Loomans, C.J., de Koning, E.J., Staal, F.J., et al. (2004) Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes. Diabetes, 53, 195-199. https://doi.org/10.2337/diabetes.53.1.195
|
[58]
|
Sharif, S., van der Graaf, Y., Nathoe, H.M., et al. (2016) HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients with Type 2 Diabetes. Diabetes Care, 39, 1424-1430. https://doi.org/10.2337/dc16-0155
|
[59]
|
Van Linthout, S., Riad, A., Dhayat, N., et al. (2007) Anti-Inflammatory Effects of Atorvastatin Improve Left Ventricular Function in Experimental Diabetic Cardiomyopathy. Diabetologia, 50, 1977-1986. https://doi.org/10.1007/s00125-007-0719-8
|
[60]
|
Vaziri, N.D. (2016) HDL Abnormalities in Nephrotic Syndrome and Chronic Kidney Disease. Nature Reviews Nephrology, 12, 37-47. https://doi.org/10.1038/nrneph.2015.180
|
[61]
|
Prufer, N., Kleuser, B. and van der Giet, M. (2015) The Role of Serum Amyloid A and Sphingosine-1-Phosphate on High-Density Lipoprotein Functionality. Biological Chemistry, 396, 573-583. https://doi.org/10.1515/hsz-2014-0192
|
[62]
|
Nishikawa, T., Edelstein, D., Du, X.L., et al. (2000) Normalizing Mitochondrial Superoxide Production Blocks Three Pathways of Hyperglycaemic Damage. Nature, 404, 787-790. https://doi.org/10.1038/35008121
|
[63]
|
Westermann, D., Rutschow, S., Van Linthout, S., et al. (2006) Inhibition of p38 Mitogen-Activated Protein Kinase Attenuates Left Ventricular Dysfunction by Mediating Pro-Inflammatory Cardiac Cytokine Levels in a Mouse Model of Diabetes Mellitus. Diabetologia, 49, 2507-2513. https://doi.org/10.1007/s00125-006-0385-2
|
[64]
|
Dewald, O., Frangogiannis, N.G., Zoerlein, M., et al. (2003) Development of Murine Is Chemic Cardiomyopathy Is Associated with a Transient Inflammatory Reaction and Depends on Reactive Oxygen Species. Proceedings of the National Academy of Sciences of the United States of America, 100, 2700-2705. https://doi.org/10.1073/pnas.0438035100
|
[65]
|
Shen, X., Zheng, S., Metreveli, N.S., et al. (2006) Protection of Cardiac Mitochondria by Overexpression of MnSOD Reduces Diabetic Cardiomyopathy. Diabetes, 55, 798-805. https://doi.org/10.2337/diabetes.55.03.06.db05-1039
|
[66]
|
Suzuki, K., Murtuza, B., Sammut, I.A., et al. (2002) Heat Shock Protein 72 Enhances Manganese Superoxide Dismutase Activity during Myocardial Is Chemia Reperfusion Injury, Associated with Mitochondrial Protection and Apoptosis Reduction. Circulation, 106, 1270-1276.
|